Share on StockTwits

Equities research analysts at Barclays assumed coverage on shares of Trupanion (NASDAQ:TRUP) in a research note issued to investors on Tuesday. The firm set an “overweight” rating on the stock.

A number of other firms have also recently commented on TRUP. Analysts at Stifel Nicolaus initiated coverage on shares of Trupanion in a research note on Tuesday. They set a “buy” rating on the stock. Analysts at RBC Capital initiated coverage on shares of Trupanion in a research note on Tuesday. They set an “outperform” rating and a $14.00 price target on the stock.

Shares of Trupanion (NASDAQ:TRUP) opened at 10.14 on Tuesday. Trupanion has a 52 week low of $9.31 and a 52 week high of $11.95. The stock has a 50-day moving average of $10.40 and a 200-day moving average of $10.40. The company’s market cap is $269.3 million.

Trupanion, Inc, is a direct-to-consumer monthly subscription service providing a medical insurance plan for cats and dogs throughout the United States, Canada and Puerto Rico.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.